Comparative analysis of an anthraquinone and chalcone derivatives-based virtual combinatorial library. A cheminformatics "proof-of-concept" study.

[1]  N. Subbarao,et al.  Discovery of multi-target mur enzymes inhibitors with anti-mycobacterial activity through a Scaffold approach , 2022, Journal of biomolecular structure & dynamics.

[2]  Yizhi Chen,et al.  Rhein Inhibits the Progression of Chemoresistant Lung Cancer Cell Lines via the Stat3/Snail/MMP2/MMP9 Pathway , 2022, BioMed research international.

[3]  Marina Sant'Anna Mitraud Ruas,et al.  The Brazilian compound library (BraCoLi) database: a repository of chemical and biological information for drug design , 2022, Molecular Diversity.

[4]  Derek S. Tan,et al.  Cheminformatic analysis of natural product-based drugs and chemical probes. , 2021, Natural product reports.

[5]  M. Lovrić,et al.  Should We Embed in Chemistry? A Comparison of Unsupervised Transfer Learning with PCA, UMAP, and VAE on Molecular Fingerprints , 2021, Pharmaceuticals.

[6]  T. Nikaido,et al.  Inhibition of cell-intrinsic NF-κB activity and metastatic abilities of breast cancer by aloe-emodin and emodic-acid isolated from Asphodelus microcarpus , 2021, Journal of Natural Medicines.

[7]  J. Medina-Franco,et al.  Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2 , 2021, RSC advances.

[8]  R. Parkesh,et al.  Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2 , 2020, Computational and Structural Biotechnology Journal.

[9]  T. Janeczko,et al.  Chalcone Methoxy Derivatives Exhibit Antiproliferative and Proapoptotic Activity on Canine Lymphoma and Leukemia Cells , 2020, Molecules.

[10]  Ya Chen,et al.  Cheminformatics in Natural Product‐based Drug Discovery , 2020, Molecular informatics.

[11]  J. Sohng,et al.  Regio-specific biotransformation of alizarin to alizarin methoxide with enhanced cytotoxicity against proliferative cells , 2020, Journal of Industrial Microbiology & Biotechnology.

[12]  Mohammed Lamine Kherfi,et al.  Considerably Improving Clustering Algorithms Using UMAP Dimensionality Reduction Technique: A Comparative Study , 2020, ICISP.

[13]  Connor W. Coley,et al.  Molecular Representation: Going Long on Fingerprints , 2020, Chem.

[14]  Thar Baker,et al.  Analysis of Dimensionality Reduction Techniques on Big Data , 2020, IEEE Access.

[15]  Giulia Caron,et al.  Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical space. , 2020, Drug discovery today.

[16]  T. Zhou,et al.  Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy. , 2020, The Journal of nutritional biochemistry.

[17]  A. Al Moustafa,et al.  Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer. , 2019, European journal of medicinal chemistry.

[18]  Zhong-hua Wu,et al.  Emodin: Its role in prostate cancer‑associated inflammation (Review). , 2019, Oncology reports.

[19]  J. P. Lee,et al.  Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives. , 2019, International journal of biological macromolecules.

[20]  Lei Wu,et al.  A Review on Dimensionality Reduction Techniques , 2019, Int. J. Pattern Recognit. Artif. Intell..

[21]  Jean-Louis Reymond,et al.  Visualization of very large high-dimensional data sets as minimum spanning trees , 2019, Journal of Cheminformatics.

[22]  Jelili Oyelade,et al.  Potential Anti-Cancer Flavonoids Isolated From Caesalpinia bonduc Young Twigs and Leaves: Molecular Docking and In Silico Studies , 2019, Bioinformatics and biology insights.

[23]  Gerard D. Wright.  Unlocking the potential of natural products in drug discovery , 2018, Microbial biotechnology.

[24]  José L Medina-Franco,et al.  BIOFACQUIM: A Mexican Compound Database of Natural Products , 2018, Biomolecules.

[25]  Thanh-Hoang Nguyen-Vo,et al.  VIETHERB: A Database for Vietnamese Herbal Species. , 2018, Journal of chemical information and modeling.

[26]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..

[27]  S. Baek,et al.  Chalcone Derivatives 4′-Amino-1-Naphthyl-Chalcone (D14) and 4′-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes , 2018, International journal of molecular sciences.

[28]  M. Mphahlele,et al.  Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[c]furan-Chalcones for Potential to Inhibit Tubulin Polymerization and/or EGFR-Tyrosine Kinase Phosphorylation , 2018, International journal of molecular sciences.

[29]  I. Matić,et al.  Highly selective anthraquinone-chalcone hybrids as potential antileukemia agents. , 2018, Bioorganic & medicinal chemistry letters.

[30]  T. Efferth,et al.  Heterocycles 44. Synthesis, characterization and anticancer activity of new thiazole ortho-hydroxychalcones , 2018, Medicinal Chemistry Research.

[31]  L. Gu,et al.  Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice , 2017, Molecular Cancer Therapeutics.

[32]  A. Andricopulo,et al.  NuBBEDB: an updated database to uncover chemical and biological information from Brazilian biodiversity , 2017, Scientific Reports.

[33]  Z. Liao,et al.  Synthesis and molecular docking study of novel alizarin derivatives containing phosphoryl amino acid moiety as potential antitumor agents , 2017, Medicinal Chemistry Research.

[34]  D. Kahraman,et al.  Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics. , 2017, European journal of medicinal chemistry.

[35]  Daeui Park,et al.  Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone. , 2017, Bioorganic & medicinal chemistry letters.

[36]  H. A. Elshemy,et al.  Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action. , 2017, Bioorganic & medicinal chemistry.

[37]  V. Sukhatme,et al.  Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase. , 2017, European journal of medicinal chemistry.

[38]  José L. Medina-Franco,et al.  Consensus Diversity Plots: a global diversity analysis of chemical libraries , 2016, Journal of Cheminformatics.

[39]  L. Deng,et al.  Synthesis and biological evaluation of rhein amides as inhibitors of osteoclast differentiation and bone resorption. , 2016, European journal of medicinal chemistry.

[40]  A. Pathania,et al.  Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity. , 2016, European journal of medicinal chemistry.

[41]  C. Supuran,et al.  Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases , 2016, Journal of enzyme inhibition and medicinal chemistry.

[42]  Jinhui Hu,et al.  Synthesis, Evaluation, and Mechanism Study of Novel Indole-Chalcone Derivatives Exerting Effective Antitumor Activity Through Microtubule Destabilization in Vitro and in Vivo. , 2016, Journal of medicinal chemistry.

[43]  D. Ribatti,et al.  Antivascular and antitumor properties of the tubulin-binding chalcone TUB091 , 2016, Oncotarget.

[44]  H. Sadeghian,et al.  15-Lipoxygenase inhibitors: a patent review , 2016, Expert opinion on therapeutic patents.

[45]  John J. Irwin,et al.  ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..

[46]  Kangdong Liu,et al.  Synthesis and Antitumor Activity of Natural Compound Aloe Emodin Derivatives , 2015, Chemical biology & drug design.

[47]  Thomas Sander,et al.  DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis , 2015, J. Chem. Inf. Model..

[48]  L. Birkholtz,et al.  Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters. , 2015, European journal of medicinal chemistry.

[49]  Z. Miao,et al.  Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents. , 2014, European journal of medicinal chemistry.

[50]  Z. Liao,et al.  Synthesis and antitumor activities of novel α-aminophosphonate derivatives containing an alizarin moiety. , 2014, European journal of medicinal chemistry.

[51]  Z. Liao,et al.  Synthesis and antitumor activities of novel rhein α-aminophosphonates conjugates. , 2014, Bioorganic & medicinal chemistry letters.

[52]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[53]  S. R. Bathula,et al.  Apoptosis and DNA intercalating activities of novel emodin derivatives , 2013 .

[54]  Daoqiang Zhang,et al.  Iterative Laplacian Score for Feature Selection , 2012, CCPR.

[55]  Christoph Steinbeck,et al.  Natural product-likeness score revisited: an open-source, open-data implementation , 2012, BMC Bioinformatics.

[56]  Hoyun Lee,et al.  Anti-breast cancer activity of heteroaryl chalcone derivatives. , 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[57]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[58]  X. Zhai,et al.  Anti‐Tumor Activity of New Artemisinin–Chalcone Hybrids , 2011, Archiv der Pharmazie.

[59]  Sarah R. Langdon,et al.  Scaffold Diversity of Exemplified Medicinal Chemistry Space , 2011, J. Chem. Inf. Model..

[60]  Jun Wang,et al.  Spectroscopic Analysis of the Interactions of Anthraquinone Derivatives (Alizarin, Alizarin-DA and Alizarin-DA-Fe) with Bovine Serum Albumin (BSA) , 2011 .

[61]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[62]  Aamir Ahmad,et al.  Fluorinated 2'-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities. , 2010, Bioorganic & medicinal chemistry letters.

[63]  Woody Sherman,et al.  Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.

[64]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[65]  Peter Ertl,et al.  Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions , 2009, J. Cheminformatics.

[66]  Rajarshi Guha,et al.  Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository , 2009, J. Chem. Inf. Model..

[67]  Adam Nelson,et al.  Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds** , 2008, Angewandte Chemie.

[68]  Michael Snowden,et al.  The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind". , 2008, Current opinion in drug discovery & development.

[69]  A. H. Lipkus,et al.  Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .

[70]  Kazutoshi Takahashi,et al.  Preparation of 1,8-di-O-alkylaloe-emodins and 15-amino-, 15-thiocyano-, and 15-selenocyanochrysophanol derivatives from aloe-emodin and studying their cytotoxic effects. , 2008, Chemical & pharmaceutical bulletin.

[71]  P. Graczyk.  Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases. , 2007, Journal of medicinal chemistry.

[72]  S. Sukdolak,et al.  MICROWAVE-ASSISTED RAPID SYNTHESIS OF PHYSCION?S DERIVATIVES UNDER SOLVENT FREE CONDITION , 2007 .

[73]  Lars Ole Haustedt,et al.  Rational approaches to natural-product-based drug design. , 2006, Current opinion in drug discovery & development.

[74]  Peter Ertl,et al.  Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. , 2006, Journal of medicinal chemistry.

[75]  N. Davidson,et al.  Anticancer activities of novel chalcone and bis-chalcone derivatives. , 2006, Bioorganic & medicinal chemistry.

[76]  Thomas Bäck,et al.  Mining a Chemical Database for Fragment Co-occurrence: Discovery of "Chemical Clichés" , 2006, J. Chem. Inf. Model..

[77]  Didier Rognan,et al.  Assessing the Scaffold Diversity of Screening Libraries , 2006, J. Chem. Inf. Model..

[78]  Deng Cai,et al.  Laplacian Score for Feature Selection , 2005, NIPS.

[79]  P. Arya,et al.  Exploring new chemical space by stereocontrolled diversity-oriented synthesis. , 2005, Chemistry & biology.

[80]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[81]  G. Schneider,et al.  Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. , 2001, Journal of combinatorial chemistry.

[82]  Helen J. Mitchell,et al.  Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid-Phase Synthesis of Benzopyrans , 2000 .

[83]  A. Harvey,et al.  Strategies for discovering drugs from previously unexplored natural products. , 2000, Drug discovery today.

[84]  P Willett,et al.  Chemoinformatics - similarity and diversity in chemical libraries. , 2000, Current opinion in biotechnology.

[85]  Bronwyn Harch,et al.  Using the Gini coefficient with BIOLOG substrate utilisation data to provide an alternative quantitative measure for comparing bacterial soil communities , 1997 .

[86]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[87]  T R Kelly,et al.  Intercalating agents with covalent bond forming capability. A novel type of potential anticancer agents. 2. Derivatives of chrysophanol and emodin. , 1989, Journal of medicinal chemistry.

[88]  K. Watanabe,et al.  Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies. , 1988, Journal of medicinal chemistry.

[89]  B. Barlogie,et al.  Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro. , 1983, Cancer research.

[90]  Peter Ertl,et al.  Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries , 2008, J. Chem. Inf. Model..

[91]  Stefan Wetzel,et al.  The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..

[92]  Richard A. Lewis,et al.  Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. , 2004, Journal of medicinal chemistry.

[93]  Miklos Feher,et al.  Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..

[94]  Dimitris K. Agrafiotis,et al.  A Constant Time Algorithm for Estimating the Diversity of Large Chemical Libraries , 2001, J. Chem. Inf. Comput. Sci..